# Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of PTSD: A Case Report > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabidiol-oil-pediatric-anxiety-insomnia-case-report/ > **Published:** 2022-07-26T16:26:18-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:16:30-04:00 > **Clinical Summary:** Explore cannabidiol oil pediatric anxiety insomnia benefits in a case report showing anxiety relief and sleep improvement in a child with PTSD symptoms. --- Cannabidiol (CBD) is a constituent of cannabis that has been demonstrated by laboratory research to deliver anxiety-relieving, anti-inflammatory benefits without psychoactive effects. However, [clinical data](https://cedclinic.com/uk-germany-medical-cannabis-markets-double-2025/) on the [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) and safety profile of CBD, especially in young children, are limited. An early case of effectiveness of CBD oil in treating symptoms of post-traumatic stress disorder (PTSD) in a pediatric patient was reported in 2016. The patient, a 10-year-old girl at the time of treatment, was sexually abused and received minimal parental supervision as a young child. She was initially diagnosed with PTSD at the age of 7, having experienced major symptoms including anxiety and sleep disorders, which contributed to her impaired ability to focus and oppositional behaviors. Over 3 years following diagnosis, she received various pharmaceutical medications, but the relief was only partial and not long-lasting, with major [side effects](https://cedclinic.com/cannabis-intoxication-memory-disruption/). A trial of CBD oil was initiated during a clinic revisit when the patient demonstrated unabated prominent symptoms. Results were encouraging: the girl experienced a sustained decrease in anxiety and steady improvement in the quality and quantity of sleep. Physicians suggest that this case provides [clinical data](https://cedclinic.com/uk-germany-medical-cannabis-markets-double-2025/) supporting the use of CBD oil as a safe and efficient treatment for reducing anxiety and improving sleep in pediatric patients, such as those suffering from PTSD. However, they acknowledge that follow-up studies, as well as controlled, large-scaled trials, are required before CBD can be medically recommended as a standard therapy. Do you have any experiences with CBD or pediatric [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/)? We’d love to hear your thoughts! [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series](https://cedclinic.com/cannabidiol-post-traumatic-stress-disorder-treatment/) Review clinical cases exploring cannabidiol's role in managing PTSD symptoms, providing context for pediatric applications. [Read More](https://cedclinic.com/cannabidiol-post-traumatic-stress-disorder-treatment/) [Cannabinoids for Children: Evidence-Based Clinical Review](https://cedclinic.com/cannabinoids-pediatric-medical-conditions-clinical-review/) An evidence-based review of cannabinoid use in pediatric populations, focusing on safety and therapeutic potential. [Explore Review](https://cedclinic.com/cannabinoids-pediatric-medical-conditions-clinical-review/) [Cannabidiol CBD Effects Autism Anxiety Clinical Trial](https://cedclinic.com/cbd-oil-autism-anxiety-trial/) [Clinical trial results](https://cedclinic.com/cannabidiol-liver-enzyme-elevation-healthy-adults/) on cannabidiol's effects on anxiety in children with autism, relevant for pediatric anxiety research. [Learn More](https://cedclinic.com/cbd-oil-autism-anxiety-trial/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Effectiveness%20of%20Cannabidiol%20Oil%20for%20Pediatric%20Anxiety%20and%20Insomnia%20as%20Part%20of%20PTSD%3A%20A%20Case%20Report&url=https%3A%2F%2Fcedclinic.com%2Fcannabidiol-oil-pediatric-anxiety-insomnia-case-report%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabidiol-oil-pediatric-anxiety-insomnia-case-report%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Effectiveness%20of%20Cannabidiol%20Oil%20for%20Pediatric%20Anxiety%20and%20Insomnia%20as%20Part%20of%20PTSD%3A%20A%20Case%20Report%20https%3A%2F%2Fcedclinic.com%2Fcannabidiol-oil-pediatric-anxiety-insomnia-case-report%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).